On one hand, as the guardian of the genome, the loss of p53 activity renders renal cells vulnerable to malignant transformation; on the other hand, there exists significant reciprocal regulation between the p53 pathway and critical renal cancer pathways such as VHL and HIF, and the imbalance among these pathways further facilitates tumor progression. The gene discussed is TP53; the disease is neoplasm.